People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zero Mass Water, Inc. | — | Other | Series D+ | $181.3M | $167.0M | 2022 |
| Phytest Diagnostics, LLC | — | Pharmaceuticals | Pre-Seed | $330K | $2.6M | 2023 |
David Crane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Crane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carmichael Roberts | 1 | 15 |
| NICHOLAS WALROD | 1 | 8 |
| Christopher Poirier | 1 | 5 |
| Joel Moxley | 1 | 3 |
| Alexis Maybank | 1 | 3 |
| William Pappas | 1 | 2 |
| Jim Matheson | 1 | 2 |
| Erik Snyder | 1 | 2 |
| Michael Idelchik | 1 | 2 |
| Al-Hussein Dahya | 1 | 1 |
| Christopher Mirick | 1 | 1 |
| Amy Ard | 1 | 1 |
| CODY FRIESEN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.